Clinical Trial Update: Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy [Phase 1]

View source ↗

Summary

Phase 1 study assessing brain penetration of voriconazole using fluorine-19 magnetic resonance spectroscopy; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infections

Drugs mentioned

• Voriconazole (Vfend) (voriconazole)

Snippet

Sponsor: Pfizer | Conditions: Fungal Infection | Phase 1 | Status: COMPLETED